Moving the Goalposts for Blood Pressure — Time to Act

We often lament the lack of confirmatory studies that can either reassure us all that the previous evidence for a trialed intervention is robust or indicate that the evidence is questionable. Zhang and colleagues have conducted such a study — the STEP trial 1 — which in essence investigates the vera...

Full description

Saved in:
Bibliographic Details
Published in:The New England journal of medicine Vol. 385; no. 14; pp. 1328 - 1329
Main Author: Nelson, Mark R
Format: Journal Article
Language:English
Published: Boston Massachusetts Medical Society 30.09.2021
Subjects:
Asymptomatic
Blood pressure
Cardiology
Cardiovascular disease
Clinical Practice
Coronary Disease
Heart attacks
Hospitalist
Hypertension
Myocardial Infarction
Nephrology
Patients
Prevention
Primary Care
Stroke
China
ISSN:0028-4793, 1533-4406, 1533-4406
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:We often lament the lack of confirmatory studies that can either reassure us all that the previous evidence for a trialed intervention is robust or indicate that the evidence is questionable. Zhang and colleagues have conducted such a study — the STEP trial 1 — which in essence investigates the veracity of the findings of the previous trial SPRINT, 2 but in an older cohort and in China, a country with a considerable burden of high blood pressure and stroke. The investigators have demonstrated impressive organizational skills in completing recruitment for such a large multicenter trial within a calendar year. As in . . .
Bibliography:SourceType-Scholarly Journals-1
content type line 14
ObjectType-Editorial-2
ObjectType-Commentary-1
content type line 23
ISSN:0028-4793
1533-4406
1533-4406
DOI:10.1056/NEJMe2112992